S
Stan Cassidy Centre for Rehabilitation | Research Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Levosimendan
CLS-7262
PGN-EDO51
Reldesemtiv
CK-2017357
Fampridine
ODM-109
CY 5031
tirasemtiv
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 10 total trials
The study consists of 3 periods: A Screening Period (up to 45 days), a Multiple Ascending Dose (MAD) Period (16 weeks), and a Long-Term Extension (LT...
Active, not recruiting
Duchenne Muscular Dystrophy
Drug: PGN-EDO51
Trial sponsors
O
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems